253 related articles for article (PubMed ID: 34423897)
1. SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease.
Mehta RS; Taylor ZL; Martin LJ; Rosen MJ; Ramsey LB
Clin Transl Sci; 2022 Jan; 15(1):63-69. PubMed ID: 34423897
[TBL] [Abstract][Full Text] [Related]
2.
Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
[No Abstract] [Full Text] [Related]
3. Association of
Ramsey LB; Moncrieffe H; Smith CN; Sudman M; Marion MC; Langefeld CD; Becker ML; Thompson SD
ACR Open Rheumatol; 2019 Mar; 1(1):58-62. PubMed ID: 31777781
[TBL] [Abstract][Full Text] [Related]
4. Effects of
Yang FF; Xue TL; Gao C; Wu Y; Lin W; Li J; Zhang RD; Zheng HY; Liu SG
Pharmacogenomics; 2022 Oct; 23(15):821-834. PubMed ID: 36193736
[No Abstract] [Full Text] [Related]
5. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
[TBL] [Abstract][Full Text] [Related]
6. Study on Relationships of Tumor Status and Gene Polymorphism With Blood Concentration of MTX and Toxicities in 63 Pediatric Mature B Cell Lymphoma in Chinese Population.
Huang S; Jin L; Yang J; Duan LY; Zhang M; Zhou JC; Zhang HY
Technol Cancer Res Treat; 2021; 20():1533033821995288. PubMed ID: 33752528
[TBL] [Abstract][Full Text] [Related]
7. SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma.
Yang L; Wu H; Gelder TV; Matic M; Ruan JS; Han Y; Xie RX
Pharmacogenomics; 2017 Nov; 18(17):1557-1562. PubMed ID: 29095107
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in Organic Anion-Transporting Polypeptide Gene Related to Methotrexate Response in Rheumatoid Arthritis Treatment.
Takahashi K; Nakamura H; Watanabe A; Majima T; Koiwa M; Kamada T; Takai S
J Nippon Med Sch; 2019; 86(3):149-158. PubMed ID: 31292326
[TBL] [Abstract][Full Text] [Related]
9. Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate.
Zhang HN; He XL; Wang C; Wang Y; Chen YJ; Li JX; Niu CH; Gao P
Pediatr Blood Cancer; 2014 Dec; 61(12):2203-7. PubMed ID: 25130190
[TBL] [Abstract][Full Text] [Related]
10. Effect of SLCO1B1 Polymorphisms on High-Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma.
Schulte RR; Choi L; Utreja N; Van Driest SL; Stein CM; Ho RH
Clin Transl Sci; 2021 Jan; 14(1):343-353. PubMed ID: 32961024
[TBL] [Abstract][Full Text] [Related]
11. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
[TBL] [Abstract][Full Text] [Related]
12. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T
Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803
[TBL] [Abstract][Full Text] [Related]
13. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
Zobeck M; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
Pharmacotherapy; 2023 Mar; 43(3):205-214. PubMed ID: 36764694
[TBL] [Abstract][Full Text] [Related]
14. [SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
Zhang H; He X; Li J; Wang Y; Wang C; Chen Y; Niu C; Gao P
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):770-6. PubMed ID: 25537545
[TBL] [Abstract][Full Text] [Related]
15. SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy.
Eldem İ; Yavuz D; Cumaoğullari Ö; İleri T; Ünal İnce E; Ertem M; Doğanay Erdoğan B; Bindak R; Özdağ H; Şatiroğlu-Tufan NL; Uysal LZ
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e289-e294. PubMed ID: 29683944
[TBL] [Abstract][Full Text] [Related]
16. Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease.
Kempinska A; Benchimol EI; Mack A; Barkey J; Boland M; Mack DR
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):389-93. PubMed ID: 21681112
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia.
Lopez-Lopez E; Martin-Guerrero I; Ballesteros J; Piñan MA; Garcia-Miguel P; Navajas A; Garcia-Orad A
Pediatr Blood Cancer; 2011 Oct; 57(4):612-9. PubMed ID: 21387541
[TBL] [Abstract][Full Text] [Related]
18. Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis.
Han JM; Choi KH; Lee HH; Gwak HS
Anticancer Drugs; 2022 Jan; 33(1):75-79. PubMed ID: 34726639
[TBL] [Abstract][Full Text] [Related]
19. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
[TBL] [Abstract][Full Text] [Related]
20. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.
Treviño LR; Shimasaki N; Yang W; Panetta JC; Cheng C; Pei D; Chan D; Sparreboom A; Giacomini KM; Pui CH; Evans WE; Relling MV
J Clin Oncol; 2009 Dec; 27(35):5972-8. PubMed ID: 19901119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]